• PLK1 Phosphorylation of p31comet Regulates Mitotic Checkpoin

  2026-05-24

  This study clarifies how Polo-like kinase 1 (PLK1) directly phosphorylates p31comet to suppress its role in disassembling mitotic checkpoint complexes, thereby ensuring the integrity of the spindle assembly checkpoint. These findings have important implications for cell cycle research and support the use of selective PLK1 inhibitors in dissecting mitotic regulation.

• Lipid Peroxidation (MDA) Assay Kit: Deciphering Ferroptosis

  2026-05-23

  Explore how the Lipid Peroxidation (MDA) Assay Kit enables advanced, quantitative malondialdehyde (MDA) detection to unravel ferroptosis mechanisms and drug resistance in cancer research. This article offers an in-depth, evidence-backed perspective on practical assay selection and interpretation, setting it apart from existing resources.

• GRK Subtype Regulation of M1 mAChR Biased Signaling Mechanis

  2026-05-22

  This study systematically dissects how G protein-coupled receptor kinase (GRK) subtypes regulate biased signaling at the M1 muscarinic acetylcholine receptor (mAChR), affecting interaction with G proteins and β-arrestin. The findings clarify molecular mechanisms underlying pathway selectivity and offer guidance for safer, more targeted research in cognitive function and Alzheimer's disease.

• Annexin V-Cy5/DAPI Apoptosis Kit: Mechanistic Precision in L

  2026-05-22

  Explore how the Annexin V-Cy5/DAPI Apoptosis Kit enables high-precision detection of apoptosis and necrosis, with unique insights into mitochondrial pathways in leukemia. This article provides advanced scientific context and practical assay guidance for cell death analysis.

• Efficient iPSC Differentiation into Retinal Ganglion Cells v

  2026-05-21

  Chavali et al. introduce a robust, chemically defined protocol that enables efficient and reproducible differentiation of human induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) by dual inhibition of SMAD and Wnt pathways. This innovation addresses longstanding challenges in variability and purity, facilitating consistent RGC generation for disease modeling and neurodegenerative research.

• Lactate-GPR81-Rac1 Signaling Enables Insulin-Independent Glu

  2026-05-21

  The reference study uncovers a novel insulin-independent pathway for glucose uptake in skeletal muscle, mediated by lactate-activated GPR81/FARP1 signaling and Rac1 activation. This mechanism highlights new therapeutic targets for hyperglycemia and informs research into Rac1 pathway inhibition and metabolic disease modulation.

• Lopinavir (ABT-378): Unveiling Serum-Resilient HIV and Coron

  2026-05-20

  Explore the unique serum-resistant potency of Lopinavir (ABT-378) in both HIV and emerging coronavirus research. This in-depth analysis integrates groundbreaking cross-viral findings and advanced assay design strategies for next-generation antiretroviral discovery.

• Morin: Applied Protocols and Innovations in Mitochondrial Re

  2026-05-20

  Morin delivers a unique combination of mitochondrial modulation and fluorescent probe utility, enabling robust assays for metabolic and neuroprotective research. This guide details workflow enhancements, protocol parameters, and troubleshooting strategies to maximize Morin’s impact in energy metabolism and disease modeling.

• FK866 (APO866): NAMPT Inhibition and Host Defense Engineerin

  2026-05-19

  Explore the dual impact of FK866 (APO866) as a NAMPT inhibitor in cancer and innate immunity research. This article unveils mechanistic insights and new application horizons beyond standard hematologic cancer models.

• Docetaxel in Oncology Research: Mechanisms, Resistance, and

  2026-05-19

  Explore the multifaceted role of Docetaxel in cancer chemotherapy research, with a focus on apoptosis induction, resistance mechanisms, and translational assay design. This article offers fresh insights into Docetaxel’s scientific applications and practical considerations in modern oncology.

• VX-661 F508del CFTR Corrector: Optimizing Rescue Workflows

  2026-05-18

  VX-661 (F508del CFTR corrector) empowers precise modulation of trafficking-deficient CFTR in cystic fibrosis research, unlocking variant-specific rescue strategies. Discover advanced workflows, data-driven troubleshooting, and novel calnexin-informed optimization for reproducible and robust CFTR rescue.

• Mechanisms of ZAK Activation at Collided Ribosomes Deciphere

  2026-05-18

  This study elucidates the mechanistic and structural basis for ZAK kinase activation during ribosome collisions, revealing how RACK1 scaffolding and SAM domain dimerization at the collision interface drive the ribotoxic stress response. These findings refine our understanding of translational quality control and have implications for kinase signaling research in cancer and stress biology.

• Mecamylamine Hydrochloride: Decoding nAChR Circuitry in Neur

  2026-05-17

  Explore the advanced mechanistic roles of Mecamylamine hydrochloride in dissecting nicotinic acetylcholine receptor pathways for neuropsychiatric disorder research. This article offers a unique, in-depth analysis bridging gut-brain axis discoveries with practical assay strategies.

• Oral Gepotidacin for Urogenital Gonorrhoea: Phase 3 Non-Infe

  2026-05-16

  The EAGLE-1 phase 3 trial demonstrates that oral gepotidacin is non-inferior to standard dual therapy for uncomplicated urogenital gonorrhoea, with high rates of microbiological cure. This work provides crucial clinical evidence for a novel oral antibiotic option amid growing antimicrobial resistance.

• VE-822 ATR Inhibitor: Mechanistic Insights and Next-Gen Assa

  2026-05-15

  Explore the molecular mechanism and practical assay optimization of VE-822, a potent ATR inhibitor. This article provides distinct, actionable insights for DNA damage response research and cancer chemoradiotherapy sensitization.

15655 records 1/1044 page Next 12345 下5页 Last page